RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations - 09/29/2

RISE to the Challenge: Statistical Considerations for Rare Disease Clinical Investigations - 09/29/2026

This public workshop, co-convened by Duke Margolis and the FDA Rare Disease Innovation Hub, will explore statistical considerations in the design, conduct, and analysis of clinical investigations for rare disease medical products.

http://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/rise-challenge-statistical-considerations-rare-disease-clinical-investigations-09292026 fda.gov

RSS Hunter • Sep 14